Fri, May 11, 2012
[ Fri, May 11th 2012 ]: Market Wire
Small Biotech Companies Look to Benefit From Improvement of U.S. Patent System
[ Fri, May 11th 2012 ]: Market Wire
Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive Kidney Transplant
[ Fri, May 11th 2012 ]: Market Wire
Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
[ Fri, May 11th 2012 ]: Market Wire
Echo Therapeutics Announces First Quarter 2012 Financial Results
[ Fri, May 11th 2012 ]: Market Wire
Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
[ Fri, May 11th 2012 ]: Market Wire
Mylan Launches Generic Lipitor in Five European Countries
[ Fri, May 11th 2012 ]: Market Wire
Dyax Corp. Launches Hereditary Angioedema (HAE) A .. kera", a Free iPhone Application for HAE Patients
[ Fri, May 11th 2012 ]: Market Wire
VentriPoint VMS(TM) Heart Analysis System Installed at Allegheny General Hospital in Pittsburgh
[ Fri, May 11th 2012 ]: Market Wire
Adherex Reports Recent Developments and First Quarter March 31, 2012 Financial Results
[ Fri, May 11th 2012 ]: Market Wire
Dr. Reddyas Revenues Cross $2 Billion Milestone* in FY12
[ Fri, May 11th 2012 ]: Market Wire
Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
[ Fri, May 11th 2012 ]: Market Wire
Crown Dynamics Shares Clinical Trial Information for AIR(R) Breathe
[ Fri, May 11th 2012 ]: Market Wire
Boston Scientific innove en offrant des garanties etendues jusqu 10ans pour ses dai et CRT-D
[ Fri, May 11th 2012 ]: Market Wire
Boston Scientific presenta garantas de hasta 10 aos para los dai y CRT-D lderes del mercado
[ Fri, May 11th 2012 ]: Market Wire
Boston Scientific gibt eine branchenfhrende garan .. eit von 10 jahren fr icd- und CRT-D-gerte bekannt
[ Fri, May 11th 2012 ]: Market Wire
Boston Scientific presenta la garanzia pi estesa .. ore: fino a 10 anni per i dispositivi icd e CRT-D
Thu, May 10, 2012
[ Thu, May 10th 2012 ]: Market Wire
GenVec Reports First Quarter 2012 Financial Results
[ Thu, May 10th 2012 ]: Market Wire
Mylan Increases 2012 Guidance Range to $2.45 to $2.55 in Adjusted Diluted EPS
[ Thu, May 10th 2012 ]: Market Wire
NuPathe Announces First Quarter 2012 Financial Results and Operational Highlights
[ Thu, May 10th 2012 ]: Market Wire
Medicure Announces Commencement of Enrollment in SAVI-PCI Trial of AGGRASTAT
[ Thu, May 10th 2012 ]: Market Wire
New England Journal of Medicine Reports on Three .. ide) Trials in Patients with Newly Diagnosed Mult
[ Thu, May 10th 2012 ]: Market Wire
New England Journal of Medicine rende note tre sp .. l REVLIMID (lenalidomide) in pazienti con mieloma
[ Thu, May 10th 2012 ]: Market Wire
00 AM Eastern;; Webcast Will Be Available
[ Thu, May 10th 2012 ]: Market Wire
Waters Corporation Presentation at the Bank of Am .. ch 2012 Health Care Conference to Be Webcast Live
[ Thu, May 10th 2012 ]: Market Wire
Alnylam Presents Final Results from a Phase I Cli .. RNAi Therapeutic Targeting Transthyretin (TTR) fo
[ Thu, May 10th 2012 ]: Market Wire
Synageva BioPharma to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
[ Thu, May 10th 2012 ]: Market Wire
Pacira Pharmaceuticals, Inc. to Present at Bank o .. America Merrill Lynch 2012 Health Care Conference
[ Thu, May 10th 2012 ]: Market Wire
Marina Biotech Receives Three Notices of Allowanc .. nt to Grant Notice From the European Patent Offic
[ Thu, May 10th 2012 ]: Market Wire
OncoSec to Present at Upcoming Investor Conference
[ Thu, May 10th 2012 ]: Market Wire
DaVita to Present 13 Abstracts at the National Kidney Foundationas 2012 Spring Clinical Meeting
[ Thu, May 10th 2012 ]: Market Wire
Capital Senior Living Corporation to Participate .. 2 Health Care and Lab Space Conference on Tuesday
[ Thu, May 10th 2012 ]: Market Wire
Centene Corporation Awarded Medicaid Contract in New Hampshire
Wed, May 9, 2012
[ Wed, May 09th 2012 ]: Market Wire
Hill-Rom Appoints Alton Shader President of Hill-Rom North America
[ Wed, May 09th 2012 ]: Market Wire
BioSyent Pharma Launches Cathejell(TM) Jelly 2%;; Shipments to Commence May 2012
[ Wed, May 09th 2012 ]: Market Wire
Telik Announces First Quarter 2012 Financial Results
[ Wed, May 09th 2012 ]: Market Wire
Sitoa Global Reports First Quarter 2012 Financial Results
[ Wed, May 09th 2012 ]: Market Wire
Watson Confirms Lialda Patent Challenge
[ Wed, May 09th 2012 ]: Market Wire
Savient Pharmaceuticals Completes Financing and Debt Restructuring Transactions
[ Wed, May 09th 2012 ]: Market Wire
Accuray presenta el sistema de planificacin de tratamiento TomoTherapy mejorado en ESTRO 31
[ Wed, May 09th 2012 ]: Market Wire
Accuray stellt erweitertes TomoTherapy-System zur Behandlungsplanung auf der ESTRO 31 vor
[ Wed, May 09th 2012 ]: Market Wire
Hospira Convenes Its 2012 Annual Meeting of Shareholders
[ Wed, May 09th 2012 ]: Market Wire
Reliv Brings Science of LunaRich to Boston on Saturday
[ Wed, May 09th 2012 ]: Market Wire
ProMetic Reports Highlights of its 2012 Annual and Special Meeting of Shareholders
[ Wed, May 09th 2012 ]: Market Wire
Nordion Launches the Gamma Centre of Excellence
[ Wed, May 09th 2012 ]: Market Wire
CEO/CFO Conference Call Series
[ Wed, May 09th 2012 ]: Market Wire
Via Surgical Ltd. Announces the Appointment of two Leading US Surgeons
[ Wed, May 09th 2012 ]: Market Wire
Prana Chief Scientific Advisor to Give Plenary Le .. sium in Stockholm Featuring New Targets and Drugs
[ Wed, May 09th 2012 ]: Market Wire
Vermillion to Present at B. Riley amp;; Co. 13th Annual Investor Conference on May 23, 2012

New England Journal of Medicine informa sobre tres ensayos de Fase III de REVLIMID (lenalidomida) en pacientes con mieloma mlti

BOUDRY, Suiza--([ ])--Celgene International Srl, filial de Celgene Corporation (NASDAQ: CELG), ha anunciado la publicacin online en la edicin del 10 de mayo, 2012 del New England Journal of Medicine de los resultados de tres estudios de fase III que evalan el uso del tratamiento continuado con REVLIMID (lenalidomida) en pacientes con mieloma mltiple de reciente diagnstico o en tratamiento de mantenimiento con lenalidomida tras un transplante antlogo de clulas madre.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda y deber ser comparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.